EV/EBITDA
-2.18
+0.03+1.36%
4 min ago
Summary
- As of February 12, 2025, QNCX EV/EBITDA is -2.18, with a rise of +0.03 (+1.36%) during the most recent trading day.
- Over the past year, QNCX EV/EBITDA has dropped by -0.35 (-19.13%).
- QNCX EV/EBITDA is now -606.98% below its all-time high of 0.43.
Performance
QNCX EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
QNCX EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
|---|---|---|---|
| todaytoday | +1.4% | -1.2% | -1.4% |
| 1 m1 month | +25.1% | -25.0% | -28.7% |
| 3 m3 months | +13.5% | -13.4% | -15.8% |
| 6 m6 months | -89.6% | +103.4% | +101.5% |
| ytdytd | +25.3% | -25.3% | -29.1% |
| 1 y1 year | -19.1% | +51.1% | +6.9% |
| 5 y5 years | +95.1% | -95.8% | -97.7% |
QNCX EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | at high | -2.91 | +25.1% | |
| 3 m | 3-month | -2.18 | at high | -3.23 | +32.5% |
| 6 m | 6-month | -0.91 | -139.6% | -3.23 | +32.5% |
| 1 y | 1-year | -0.75 | -190.7% | -3.23 | +32.5% |
| 3 y | 3-year | 0.43 | -607.0% | -3.23 | +32.5% |
| 5 y | 5-year | 0.43 | -607.0% | -53.32 | +95.9% |
| alltime | all time | 0.43 | -607.0% | -75.99 | +97.1% |
Quince Therapeutics EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | -2.18(-25.3%) |
| 2024 | -2.92(+111.6%) |
| 2023 | -1.38(-420.9%) |
| Date | Value |
|---|---|
| 2022 | 0.43(-112.4%) |
| 2021 | -3.46(-64.0%) |
| 2020 | -9.60(-74.3%) |
| 2019 | -37.38 |
FAQ
- What is Quince Therapeutics EV/EBITDA?
- What is the all time high EV/EBITDA for Quince Therapeutics?
- What is QNCX EV/EBITDA year-to-date change?
- What is Quince Therapeutics EV/EBITDA year-on-year change?
What is Quince Therapeutics EV/EBITDA?
The current EV/EBITDA of QNCX is -2.18
What is the all time high EV/EBITDA for Quince Therapeutics?
Quince Therapeutics all-time high EV/EBITDA is 0.43
What is QNCX EV/EBITDA year-to-date change?
Quince Therapeutics EV/EBITDA has changed by +0.74 (+25.34%) since the beginning of the year
What is Quince Therapeutics EV/EBITDA year-on-year change?
Over the past year, QNCX EV/EBITDA has changed by -0.35 (-19.13%)